Cargando…

SUN-036 Evaluation of Gender Experience Among Individuals with Isolated GnRH Deficiency Compared to Controls

Background: Sex hormones play a role in gender identity development. For example, 46,XY individuals with complete androgen insensitivity typically have a female gender identity. Isolated GnRH deficiency (IGD) leads to hypogonadism due to decreased GnRH-induced gonadotropin production. It is unknown...

Descripción completa

Detalles Bibliográficos
Autores principales: Persky, Rebecca, Han, Joan C, Neyman, Anna, Rohn, Reuben D, Balasubramanian, Ravikumar, Seminara, Stephanie Beth, Hall, Janet Elizabeth, Delaney, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209743/
http://dx.doi.org/10.1210/jendso/bvaa046.239
_version_ 1783531149732085760
author Persky, Rebecca
Han, Joan C
Neyman, Anna
Rohn, Reuben D
Balasubramanian, Ravikumar
Seminara, Stephanie Beth
Hall, Janet Elizabeth
Delaney, Angela
author_facet Persky, Rebecca
Han, Joan C
Neyman, Anna
Rohn, Reuben D
Balasubramanian, Ravikumar
Seminara, Stephanie Beth
Hall, Janet Elizabeth
Delaney, Angela
author_sort Persky, Rebecca
collection PubMed
description Background: Sex hormones play a role in gender identity development. For example, 46,XY individuals with complete androgen insensitivity typically have a female gender identity. Isolated GnRH deficiency (IGD) leads to hypogonadism due to decreased GnRH-induced gonadotropin production. It is unknown if decreased sex hormone exposure leads to differences in gender identity among individuals with IGD compared with the general population. Our objective was to determine if the gender identity in subjects with IGD differs from controls. Methods: We distributed a validated questionnaire; the Gender Identity/Gender Dysphoria Questionnaire for Adults and Adolescents (GIDYQ-AA) (1), to IGD participants who previously enrolled in a phenotyping study. Subjects also provided their age, sex assigned at birth (SAAB), gender and information about their condition and treatment. Group survey scores are expressed as mean ± SD. IGD subject scores were compared with control data (Student’s t-test) obtained from a validation study for the GIDYQ-AA (2). Results: Out of 79 subjects who were contacted, 8 males (M) assigned at birth and 7 females (F) assigned at birth chose to participate and one person actively declined. Average age was 30 y for F and 28 y for M. At the time of the study, all subjects were on hormone supplementation except for one F. A score of 5 indicates a gender identity congruent with SAAB. Among F, mean scaled IGD score was 4.73 ± 0.29 vs. controls (4.8 ± 0.28, n=57; not significant (ns)), and for M it was 4.62 ± 0.52 vs. controls (4.82 ± 0.24, n=37; ns). One female identified as “non-gendered”, one male identified as “intersex/DSD” (14% of respondents), one female did not respond and gender was congruent with SAAB in the remainder. The lowest mean score for an individual question for the IGD F group was in response to whether they felt satisfied being a woman and for the IGD M group, it was in response to whether they felt they were a real man. Conclusions: Men and women with IGD did not show a significant difference in their gender identity compared with controls, and gender was found to be congruent with SAAB for the majority. However, the individual question responses and the self-described gender in this small cohort may suggest that there are differences in how some individuals with IGD experience their gender development. We speculate that this may be related to how they perceive the differences in physical development that they experienced related to their condition. Larger studies in participants with IGD and other disorders that alter sex hormone production/effect are necessary to further understand the relationship between decreased sex hormone exposure during critical developmental periods and gender identity development. References: (1) Deogracias, J.J, et al. J. Sex Res., 2007, 44:4, 370–379 (2) Singh, D. et al. J. Sex Res. 2010, 47:1, 49–58
format Online
Article
Text
id pubmed-7209743
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72097432020-05-13 SUN-036 Evaluation of Gender Experience Among Individuals with Isolated GnRH Deficiency Compared to Controls Persky, Rebecca Han, Joan C Neyman, Anna Rohn, Reuben D Balasubramanian, Ravikumar Seminara, Stephanie Beth Hall, Janet Elizabeth Delaney, Angela J Endocr Soc Reproductive Endocrinology Background: Sex hormones play a role in gender identity development. For example, 46,XY individuals with complete androgen insensitivity typically have a female gender identity. Isolated GnRH deficiency (IGD) leads to hypogonadism due to decreased GnRH-induced gonadotropin production. It is unknown if decreased sex hormone exposure leads to differences in gender identity among individuals with IGD compared with the general population. Our objective was to determine if the gender identity in subjects with IGD differs from controls. Methods: We distributed a validated questionnaire; the Gender Identity/Gender Dysphoria Questionnaire for Adults and Adolescents (GIDYQ-AA) (1), to IGD participants who previously enrolled in a phenotyping study. Subjects also provided their age, sex assigned at birth (SAAB), gender and information about their condition and treatment. Group survey scores are expressed as mean ± SD. IGD subject scores were compared with control data (Student’s t-test) obtained from a validation study for the GIDYQ-AA (2). Results: Out of 79 subjects who were contacted, 8 males (M) assigned at birth and 7 females (F) assigned at birth chose to participate and one person actively declined. Average age was 30 y for F and 28 y for M. At the time of the study, all subjects were on hormone supplementation except for one F. A score of 5 indicates a gender identity congruent with SAAB. Among F, mean scaled IGD score was 4.73 ± 0.29 vs. controls (4.8 ± 0.28, n=57; not significant (ns)), and for M it was 4.62 ± 0.52 vs. controls (4.82 ± 0.24, n=37; ns). One female identified as “non-gendered”, one male identified as “intersex/DSD” (14% of respondents), one female did not respond and gender was congruent with SAAB in the remainder. The lowest mean score for an individual question for the IGD F group was in response to whether they felt satisfied being a woman and for the IGD M group, it was in response to whether they felt they were a real man. Conclusions: Men and women with IGD did not show a significant difference in their gender identity compared with controls, and gender was found to be congruent with SAAB for the majority. However, the individual question responses and the self-described gender in this small cohort may suggest that there are differences in how some individuals with IGD experience their gender development. We speculate that this may be related to how they perceive the differences in physical development that they experienced related to their condition. Larger studies in participants with IGD and other disorders that alter sex hormone production/effect are necessary to further understand the relationship between decreased sex hormone exposure during critical developmental periods and gender identity development. References: (1) Deogracias, J.J, et al. J. Sex Res., 2007, 44:4, 370–379 (2) Singh, D. et al. J. Sex Res. 2010, 47:1, 49–58 Oxford University Press 2020-05-08 /pmc/articles/PMC7209743/ http://dx.doi.org/10.1210/jendso/bvaa046.239 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Reproductive Endocrinology
Persky, Rebecca
Han, Joan C
Neyman, Anna
Rohn, Reuben D
Balasubramanian, Ravikumar
Seminara, Stephanie Beth
Hall, Janet Elizabeth
Delaney, Angela
SUN-036 Evaluation of Gender Experience Among Individuals with Isolated GnRH Deficiency Compared to Controls
title SUN-036 Evaluation of Gender Experience Among Individuals with Isolated GnRH Deficiency Compared to Controls
title_full SUN-036 Evaluation of Gender Experience Among Individuals with Isolated GnRH Deficiency Compared to Controls
title_fullStr SUN-036 Evaluation of Gender Experience Among Individuals with Isolated GnRH Deficiency Compared to Controls
title_full_unstemmed SUN-036 Evaluation of Gender Experience Among Individuals with Isolated GnRH Deficiency Compared to Controls
title_short SUN-036 Evaluation of Gender Experience Among Individuals with Isolated GnRH Deficiency Compared to Controls
title_sort sun-036 evaluation of gender experience among individuals with isolated gnrh deficiency compared to controls
topic Reproductive Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209743/
http://dx.doi.org/10.1210/jendso/bvaa046.239
work_keys_str_mv AT perskyrebecca sun036evaluationofgenderexperienceamongindividualswithisolatedgnrhdeficiencycomparedtocontrols
AT hanjoanc sun036evaluationofgenderexperienceamongindividualswithisolatedgnrhdeficiencycomparedtocontrols
AT neymananna sun036evaluationofgenderexperienceamongindividualswithisolatedgnrhdeficiencycomparedtocontrols
AT rohnreubend sun036evaluationofgenderexperienceamongindividualswithisolatedgnrhdeficiencycomparedtocontrols
AT balasubramanianravikumar sun036evaluationofgenderexperienceamongindividualswithisolatedgnrhdeficiencycomparedtocontrols
AT seminarastephaniebeth sun036evaluationofgenderexperienceamongindividualswithisolatedgnrhdeficiencycomparedtocontrols
AT halljanetelizabeth sun036evaluationofgenderexperienceamongindividualswithisolatedgnrhdeficiencycomparedtocontrols
AT delaneyangela sun036evaluationofgenderexperienceamongindividualswithisolatedgnrhdeficiencycomparedtocontrols